Pacira BioSciences [PCRX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Pacira BioSciences Inc.

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Pacira BioSciences Inc. wins in 8 metrics, Haleon Plc - ADR wins in 11 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pacira BioSciences Inc. Haleon Plc - ADR Better
P/E Ratio (TTM) 154.00 18.72 Haleon Plc - ADR
Price-to-Book Ratio 1.46 1.88 Pacira BioSciences Inc.
Debt-to-Equity Ratio 60.34 52.37 Haleon Plc - ADR
PEG Ratio -1.74 15.42 Haleon Plc - ADR
EV/EBITDA 9.47 33.08 Pacira BioSciences Inc.
Profit Margin (TTM) 0.97% 15.11% Haleon Plc - ADR
Operating Margin (TTM) -1.17% 23.17% Haleon Plc - ADR
EBITDA Margin (TTM) N/A 23.17% N/A
Return on Equity 0.96% 10.27% Haleon Plc - ADR
Return on Assets (TTM) 1.48% 4.67% Haleon Plc - ADR
Free Cash Flow (TTM) $136.66M $2.22B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return -10.14% -20.18% Pacira BioSciences Inc.
Price-to-Sales Ratio (TTM) 1.46 3.78 Pacira BioSciences Inc.
Enterprise Value $1.18B $122.54B Haleon Plc - ADR
EV/Revenue Ratio 1.62 8.23 Pacira BioSciences Inc.
Gross Profit Margin (TTM) 79.53% 55.38% Pacira BioSciences Inc.
Revenue per Share (TTM) $16 $2 Pacira BioSciences Inc.
Earnings per Share (Diluted) $0.16 $0.50 Haleon Plc - ADR
Beta (Stock Volatility) 0.20 0.33 Pacira BioSciences Inc.
Short % of Float 29.98% 0.43% Haleon Plc - ADR

Pacira BioSciences Inc. vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

PCRX
HLN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pacira BioSciences Inc.0.31%-8.70%-9.92%4.51%-7.60%-9.08%
Haleon Plc - ADR0.23%-5.84%-5.84%-19.96%-10.03%-13.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pacira BioSciences Inc.-10.14%-40.60%-61.90%-50.69%67.77%230.30%
Haleon Plc - ADR-20.18%9.16%22.27%22.27%22.27%22.27%

Performance & Financial Health Analysis: Pacira BioSciences Inc. vs Haleon Plc - ADR

MetricPCRXHLN
Market Information
Market Cap i$1.09B$42.40B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i455,1446,594,249
90 Day Avg. Volume i642,2017,985,230
Last Close$22.32$8.72
52 Week Range$18.80 - $27.64$8.65 - $11.30
% from 52W High-19.25%-22.83%
All-Time High$121.95 (Feb 23, 2015)$11.42 (Jun 02, 2025)
% from All-Time High-81.70%-23.64%
Growth Metrics
Quarterly Revenue Growth0.05%0.01%
Quarterly Earnings Growth-0.90%0.86%
Financial Health
Profit Margin (TTM) i0.01%0.15%
Operating Margin (TTM) i-0.01%0.23%
Return on Equity (TTM) i0.01%0.10%
Debt to Equity (MRQ) i60.3452.37
Cash & Liquidity
Book Value per Share (MRQ)$16.86$4.99
Cash per Share (MRQ)$5.89$0.15
Operating Cash Flow (TTM) i$151.99M$3.56B
Levered Free Cash Flow (TTM) i$108.56M$1.89B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Pacira BioSciences Inc. vs Haleon Plc - ADR

MetricPCRX (Apr 24, 2026)HLN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i154.0018.72
Forward P/E i7.0215.42
PEG Ratio i-1.7415.42
Price to Sales (TTM) i1.463.78
Price to Book (MRQ) i1.461.88
Market Capitalization
Market Capitalization i$1.09B$42.40B
Enterprise Value i$1.18B$122.54B
Enterprise Value Metrics
Enterprise to Revenue i1.628.23
Enterprise to EBITDA i9.4733.08
Risk & Other Metrics
Beta i0.200.33
Book Value per Share (MRQ) i$16.86$4.99

Financial Statements Comparison: Pacira BioSciences Inc. vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPCRX (2025)HLN (2025)
Revenue/Sales i726.41M11.03B
Cost of Goods Sold i149.75M3.95B
COGS % of Revenue i20.6%35.8%
Gross Profit i576.66M7.08B
Gross Margin i79.4%64.2%
Research & Development i117.31M316.00M
Operating Income (EBIT) i33.30M2.41B
Operating Margin i4.6%21.9%
EBITDA i137.60M2.81B
EBITDA Margin i18.9%25.5%
Pre-Tax Income i16.87M2.15B
Pre-Tax Income % of Revenue i2.3%19.5%
Income Tax i9.84M472.00M
Income Tax % of Revenue i1.4%4.3%
Net Income (Profit) i7.03M1.68B
Profit Margin i1.0%15.2%

Balance Sheet & Liquidity Metrics

MetricPCRX (2025)HLN (2025)
Cash & Equivalents i158.55M1.26B
Total Current Assets i547.97M4.55B
Total Current Assets % of Revenue i75.4%41.3%
Total Current Liabilities i120.59M4.93B
Total Current Liabilities % of Revenue i16.6%44.7%
Long-Term Debt i408.37M7.75B
Long-Term Debt % of Revenue i56.2%70.2%
Total Shareholders Equity i693.11M16.48B
Retained Earnings i-199.32M27.85B
Retained Earnings % of Revenue i-27.4%252.5%
Property, Plant & Equipment i41.78M1.00M

Cash Flow Statement Comparison

MetricPCRX (2025)HLN (2025)
Operating Cash Flow i108.50M2.19B
Operating Cash Flow % of Revenue i14.9%19.8%
Capital Expenditures i-15.33M-322.00M
Free Cash Flow i136.66M2.22B
FCF Margin i18.8%20.1%
Debt Repayment i-317.80M-1.35B
Common Stock Repurchase i-148.33M-654.00M

Short Interest & Institutional Ownership Analysis

MetricPCRXHLN
Shares Short i8.06M19.28M
Short Ratio i9.812.14
Short % of Float i29.98%0.43%
Shares Outstanding i41.12M8.91B
Float Shares i37.64M8.86B
% Held by Insiders i3.32%0.01%
% Held by Institutions i118.71%12.74%
% Held by Public i-22.03%87.25%

Dividend Analysis & Yield Comparison: Pacira BioSciences Inc. vs Haleon Plc - ADR

MetricPCRXHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025